Our results showed that the WEE1 inhibitor, MK-1775 (Fig. 2A), and talazoparib (Fig. 2B) inhibited the proliferation of all the MDS and AML cell lines. The gene discussed is WEE1; the disease is myelodysplastic syndrome.